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Introduction
Spontaneous cervical artery dissection (sCAD) is a well-
recognized cause of stroke, especially in young patients, 
with a wide spectrum of clinical presentations [1, 2]. Pa-
tients may present with isolated local manifestations, 
ischemic signs or both [3]. However, the most appropri-
ate end point in follow-up studies remains unclear: sev-
eral studies used functional outcome, measured with the 
modified Rankin Scale score (mRS) or the recurrence 
rate. But the recurrence rate is low and an excellent out-
come measured with the mRS is seen in the majority of 
these patients in hospital- and population-based studies 
[4, 5]. But since the mRS captures only functional dis-
ability, it may not be sensitive enough to assess the se-
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■ Abstract  Background and pur-
pose Little data exists about long-
term outcome, quality of life (QOL) 
and its predictors after spontane-
ous cervical artery dissections 
(sCAD). Methods Clinical and ra-
diological data of 114 patients with 
sCAD were collected prospectively. 
Six patients died within 3 months, 
the remaining 108 were contacted 
after a mean of 1498 days (range: 
379–3455), 99 survivors (92 %) 
 replied. QOL, assessed with the 
stroke-specific QOL scale (SS-
QOL), and functional abilities, 
measured with modified Rankin 
Scale (mRS) were compared, and 
predictors of QOL were analyzed. 
Subgroup analyses were performed 
for patients with ischemic stroke, 
those with isolated local symptoms 
or transient ischemic symptoms 
and those without significant dis-
abilities (mRS 0–1) at follow-up. 
Results Seventy-one of 99 patients 
(72 %) had no significant disability, 
but only 53 (54 %) reported a good 
QOL (SS-QOL ≥ 4). Compared to 
the self-rated premorbid QOL of all 
patients, SS-QOL was impaired 
 after sCAD (p < 0.001); impairment 
of QOL was observed in patients 
with ischemic stroke (p < 0.001), in 
patients with isolated local or 
 transient ischemic symptoms 
(p < 0.038) and those without sig-
nificant disabilities at follow-up 
(p = 0.013). Nevertheless, low mRS 
was associated with better overall 
QOL (Kendall’s tau > 0.5). High 
 National Institute of Health Stroke 
Scale score on admission and 
higher age were  independent pre-
dictors of impaired QOL (p < 0.05). 
Conclusion QOL is impaired in 
 almost half of long-term survivors 
after sCAD, even in patients with 
local or transient symptoms or 
without functional disability. Im-
pairment of QOL is a surprisingly 
frequent long-term sequela after 
sCAD and  deserves attention as an 
outcome measure in these patients.
■ Key words  cervical artery dis-
section · quality of life · outcome 
research
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quelae in patients with sCAD, especially those with tran-
sient or local symptoms and patients with no functional 
disability at follow-up. 
QOL scales measuring patient centered outcome are 
sensitive for minimal changes and do not focus on gross 
physical aspects of disability only, but include psycho-
logical and cognitive functions like memory, emotion, 
thinking, communication and social role, which may be 
impaired in patients who have suffered a potentially life-
threatening event such as sCAD.
The aim of the present study was therefore to deter-
mine QOL, functional dependency and social status in 
survivors after sCAD. We analyzed whether QOL was 
impaired compared to the premorbid condition in all 
patients and in subgroups (patients with ischemic stroke, 
those with isolated local symptoms or transient is chemic 
symptoms and those without significant disabilities 
(mRS 0–1) at follow-up). In addition, we analyzed 
whether baseline data on hospital admission predict 
QOL at long-term follow-up.
Methods
■ Investigations
We prospectively collected data at our stroke center on consecutive 
patients, presenting with first-ever sCAD from January 1997 to Sep-
tember 2005. Patients with a cervical artery dissection due to major 
trauma were excluded from this study. All patients underwent a neu-
rological examination, routine blood examination, electrocardiogra-
phy, magnetic resonance imaging (MRI) of the brain, cervical MRI 
with T1 fat suppression and magnetic resonance angiography (MRA) 
or digital subtraction angiography of the four cervical arteries. Inter-
nal carotid (ICAD) and/or vertebral artery (VAD) dissection was con-
sidered proven if the affected vessel showed an intramural hematoma 
on axial cervical MRI cuts, or a string sign, intimal flap or pseudoan-
eurysm on angiography [6–8]. 
■ Classification and risk factors 
A sCAD was classified as spontaneous when occurring spontaneously 
or secondary to minimal trauma [9]. Dissections occurring after ob-
vious head or neck trauma were classified as traumatic and were ex-
cluded from the study. sCAD were differentiated into those with and 
without focal ischemic deficits of the brain, retina, or both. Ischemic 
deficits were classified according to their duration as stroke (> 24 
hours), transient ischemic attack (TIA; ≤ 24 hours). The following lo-
cal signs and symptoms were assessed: headache, neck pain, Horner’s 
syndrome, pulsatile tinnitus and cranial nerve palsy located on the 
side of dissection. Risk factors for ischemic stroke and sCAD were 
assessed as reported previously [10]. Arterial hypertension was de-
fined as a positive history of treated or untreated hypertension. A 
history of migraine with or without aura was diagnosed by a neurolo-
gist based on the International Headache Society’s criteria [11, 12]. 
The neurological deficit on admission was graded in all patients using 
the National Institute of Health Stroke Scale (NIHSS) score [13]. 
■ Treatment
Patients with extracranial sCAD were treated with intravenous hepa-
rin, followed by oral warfarin with an international target normalized 
ratio of 2.5 (range 2.0–3.0) for 3–6 months, unless the patient suffered 
a hemispheric infarction with a high risk of secondary hemorrhage. 
Patients with large infarcts or with intracranial extension of a spon-
taneous VAD received aspirin 100–300 mg/d for 3–6 months, if no 
subarachnoid hemorrhage was present on computed tomography or 
MRI. 
■ QOL and functional outcome measurement
QOL was assessed with the stroke specific quality of life scale (SS-
QOL) [14]. The SS-QOL is a disease-specific QOL scale, assessing 12 
domains (energy, family roles, language, mobility, mood, personality, 
self-care, social roles, thinking, upper extremity function, vision and 
work) (Link to the questionnaire: http://www.strokecenter.org/trials/
scales/ssqol.html). Each item is ranked on a 5-point Likert scale, with 
higher scores indicating better function. Domain scores are un-
weighted averages of the items compromising that domain, and the 
summary SS-QOL is an unweighted average of the 12 domain scores. 
A summary SS-QOL score of ≥ 4 was considered to indicate good 
QOL, < 4 an impaired QOL. Functional outcome was measured using 
the mRS [15]. Favorable outcome was defined as mRS 0–1, unfavor-
able outcome as mRS 2 to 6.
■ Follow-up
Functional outcome and QOL were assessed from February 2006 to 
March 2007. If a patient was not able to communicate via phone, e. g., 
because of aphasia, a caregiver was contacted. In a structured tele-
phone interview mRS, residential status, occupation and marital sta-
tus were assessed [16]. QOL was assessed using the SS-QOL question-
naire, which was sent to patients after the phone contact. They were 
asked to rate their QOL in the month before their dissection and in 
the month prior to follow-up. In addition, we asked whether the pa-
tient needed help from their proxies to answer the questions. 
■ Statistical analysis 
Statistical analysis was performed using SPSS 13 for Macintosh statis-
tical software (SPSS Inc.©, 2001). Demographic data are given as 
mean values. The NIHSS score is given as a median value. Correlation 
between functional outcome and QOL was measured with non-para-
metric correlations (Kendall’s tau). Continuous variables were com-
pared with the t-test for normal or the Mann-Whitney U test for ab-
normal distributed variables. Categorical variables were compared 
with χ² and Fisher’s exact test as appropriate. QOL of all patients and 
subgroups (patients with ICAD and VAD; survivors with the follow-
ing presenting symptoms: ischemic stroke, those with isolated local 
symptoms or transient ischemic symptoms, those with no or minimal 
disabilities [mRS 0 or 1] and those with severe disabilities [mRS 2 to 
5] at follow-up), were compared with the self-rated QOL before dis-
section in all patients. Before performing the multivariate regression 
analysis, a univariate analysis was performed. Variables available at 
hospital admission were tested one by one against the dependent vari-
able, and variables without association (p > 0.2) were removed from 
the model. The dependent variable was QOL, dichotomized as men-
tioned above. Then logistic regression analysis with the forward step-
wise method was performed to determine the independent associa-
tion of QOL with other clinical factors. A two sided p-value < 0.05 was 
considered statistically significant. 
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Results
■ Baseline data
From January 1997 to September 2005, 114 consecutive 
patients with a sCAD were hospitalized in our stroke 
center. Six patients died within the first 3 months. Base-
line characteristics of 108 survivors (50 women, 58 men; 
mean age 46 years) are shown in Table 1. Eighty-seven 
patients had an ICAD, 19 a VAD and 2 a dissection of 
both vessels. Twenty-eight patients presented with tran-
sient or local symptoms, and 80 patients had an ischemic 
stroke or a retinal infarction. The 108 survivors were 
contacted after a mean of 1498 days (range 379–3455). 
Ninety-eight of the 108 survivors (91 %) were contacted 
by phone, 9 patients were lost to follow-up and one pa-
tient returned the questionnaire, but could not be 
reached by phone. Outcome at follow-up, measured with 
the mRS, is given in Table 2.
■ QOL before and after sCAD
The SS-QOL questionnaire was completed by 99 of the 
108 survivors (92 %). Seventy-four survivors (75 %) were 
able to complete the questionnaires without help. SS-
QOL before dissection was rated as good in 92 of 99 sur-
vivors (93 %), after dissection in 53 patients (54 %). 
Compared to the self-rated QOL of all patients before 
dissection, SS-QOL was significantly lower after sCAD 
(p < 0.001): mean SS-QOL before dissection was 4.63 
(95 % confidence interval (CI) 4.55–4.71) and 3.87 (95 % 
CI 3.69–4.05) after dissection (Fig. 1).
■ QOL and functional outcome (mRS)
There was an overall correlation of high mRS and im-
paired QOL (p < 0.001): patients with a high mRS score 
were more likely to suffer from an impaired QOL (Ken-
dall’s tau > 0.5). Nevertheless, 21 of 71 patients (30 %) 
with a favorable outcome (mRS 0–1) reported an im-
paired QOL. Only 2 of 27 patients (7 %) with an unfavor-
able outcome (mRS 2–5) experienced a good QOL.
■ Subgroup analysis
SS-QOL varied among subgroups (Fig. 1). QOL was best 
in survivors with transient or local symptoms and worst 
in disabled patients due to stroke (mRS 2–5). A signifi-
cantly impaired QQL compared to the overall QOL be-
fore dissection was not only observed in patients with an 
ischemic stroke (p < 0.001), but also in patients with iso-
lated local or transient ischemic symptoms (p < 0.038) 
and in patients without a disability (mRS = 0–1) at fol-
low-up (p = 0.013). SS-QOL was similar in patients with 
VAD (mean: 3.74, SD: 1.13) and ICAD (mean: 3.92, SD: 
0.85) (p > 0.05). Patients with stroke and with local or 
Table 1  Baseline characteristics of survivors (n = 108)
 Variable
 Age at symptom onset, mean, (SD; range) 46 years (9; 18–78)
 Female, n (%) 50 (46 %)
 Baseline NIHSS score, median (range)  4 (0–31)
 Time from symptom onset to diagnosis, median (range)  2 days (0–32)
 Affected vessel
  Carotid artery dissections, n (%) 87 (80 %)
    Bilateral, n  3
  Vertebral artery dissections, n (%) 19 (18 %)
    Bilateral, n  1
  Carotid and vertebral artery dissections, n (%)  2 (2 %)
 Presenting clinical findings on hospital admission, n (%)
  Ischemic stroke 79 (73 %)
  TIA 11 (10 %)
  Retinal infarction  1 (1 %)
  Local symptoms only 17 (16 %)
 Other symtpoms at hospital admission, n (%)
  Headache 79 (73 %)
  Neck pain 29 (27 %)
  Horner’s syndrome 42 (38 %)
  Tinnitus  9 (8 %)
  Cranial nerve involvement  2 (2 %)
 Risk factors, n (%)
  Hypercholesterolemia 36 (33 %)
  Current smoking 26 (24 %)
  Diabetes mellitus  2 (2 %)
  Hypertension 26 (24 %)
  Family history of stroke 16 (15 %)
  History of migraine 25 (23 %)
  History of preceding minor trauma 16 (15 %)
Table 2  Outcome 
 Modified Rankin Scale 
 All (CAD and VAD), n = 108
  mRS 0–1, n (%) 71 (66 %)
  mRS 2–5, n (%) 27 (25 %)
  Lost to follow-up, n (%)  9 (8 %)
  Missing data, n (%)  1 (1 %)
 Carotid artery dissection, n = 87
  mRS 0–1, n (%) 56 (65 %)
  mRS 2–5, n (%) 22 (25 %)
  Missing data, n (%)  1 (1 %)
  Lost to follow-up, n (%)  8 (9 %)
 Vertebral artery dissection, n = 19
  mRS 0–1, n (%) 14 (74 %)
  mRS 2–5, n (%)  5 (26 %)
 Carotid and vertebral artery dissection, n = 2
  Lost to follow-up, n  1
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transient symptoms did not differ regarding sex, vascu-
lar risk factors and time to follow-up (p > 0.05).
■ Subitems of QOL
Figs. 2 and 3 show the different items of the SS-QOL in 
patients before and after dissection. The biggest change 
in QOL in survivors without significant disabilities at 
follow-up (mRS 0–1) could be observed in the items 
“thinking”, “energy” and “language”, whereas in the do-
mains “self care”, “personality” and “mood” the smallest 
change could be assessed. In patients with local or tran-
sient symptoms QOL decreased most in the domains 
“thinking”, “energy” and “personality”, whereas “mood”, 
“family roles”, “self-care”, “social roles” and “upper ex-
tremity function” were hardly impaired. 
■ Residential status, occupation and marital status
At follow-up, 86 patients (88 %) were living in their home 
without help, 10 (10 %) with help and 2 (2 %) in a nurs-
ing home. 81 survivors were able to communicate via 
phone. Before sCAD, 90 patients had been working full 
time, 8 part-time. After sCAD, 45 survivors had resumed 
full-time employment, 24 part-time, 2 were retired, 2 
were unemployed and 24 were no longer able to work 
because of their handicap. Marital status did not change 
significantly before and after sCAD: one patient married 
after her sCAD.
■ Predictors of QOL
In a multivariate logistic regression analysis, higher 
NIHSS score on admission (odds ratio (OR): 0.853; 95 % 
confidence interval (CI): 0.788–0.922; p < 0.001) and 
higher age (OR: 0.914; CI: 0.860–0.971; p = 0.003) were 
independent predictors of an impaired QOL. Time inter-
val from symptom onset to diagnosis (p = 0.249), minor 
trauma before dissection (p = 0.435), cephalgia 
(p = 0.360), cervicalgia (p = 0.188), tinnitus (p = 0.260) 
and Horner’s syndrome (p = 0.114) were not indepen-
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Fig. 1  SS-QOL in survivors after spontaneous cervical artery dissection (sCAD). 
SS-QOL ranges from 1 to 5 with higher scores indicating better function. The black 
bar (4.63) shows the mean value of SS-QOL in all patients before their sCAD. CI con-
fidence interval; p p value (A two sided p-value < 0.05 was considered statistically 
significant); mRS modified Rankin Scale; Stroke all patients with ischemic stroke 
and or retinal ischemia; No Stroke all patients with a transient ischemic attack or 
local symptoms
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Before Dissection (n=99) mRS 0–1 (n=71) mRS 2–5 (n=27)Fig. 2  SS-QOL in patients before spontaneous 
cervical artery dissection (sCAD) and in survivors 
with a favorable (mRS 0–1) and an unfavorable 
(mRS 2–5) outcome. SS-QOL ranges from 1 to 5 with 
higher scores indicating better function. mRS modi-
fied Rankin Scale; Stroke all patients with ischemic 
stroke and or retinal ischemia; No Stroke all patients 
with a transient ischemic attack or local symptoms; 
UE function upper extremity function
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dently associated with QOL in the multivariate analy-
sis. 
Discussion
In this study we analyzed QOL and long-term functional 
outcome in survivors after sCAD. After a mean follow-up 
of 4 years, 72 % of the patients had no significant func-
tional disabilities (mRS 0–1). Patients’ opinion of out-
come differed significantly from the functional outcome 
assessed with the mRS. When using QOL measures only 
54 % of all survivors reported a good QOL (SS-QOL ≥ 4). 
This is the main finding of our study analyzing func-
tional outcome and QOL in all survivors after sCAD. 
In general, QOL was worse in handicapped patients 
than in those without significant disabilities, a fact al-
ready previously shown in other patients with stroke 
[17]. However, when compared to the premorbid condi-
tion of all patients, QOL was not only impaired in the 
disabled, but also in those without significant disabili-
ties at follow-up and in survivors without an ischemic 
stroke. This interesting finding reflects our clinical ob-
servation that some of these patients are complaining of 
discomfort even years after their dissection despite no 
obvious physical abnormalities. sCAD affects mostly 
young and previously healthy patients, who are not ex-
pecting such an incident, which is often experienced as 
a life-threatening event. Survivors are concerned about 
suffering a second dissection, even when aware of the 
low recurrence rate and the generally favorable outcome 
[5, 18]. The lack of a convincing scientific explanation 
for the pathogenesis and etiology of sCAD worries some 
patients. In contrast to a stroke due to atherosclerosis, 
the chance of having a sCAD is not associated with vas-
cular risk factors and hence is not predictable. There-
fore, primary and secondary prevention measures are 
scarce and patients cannot influence their destiny. 
Domains of the SS-QOL that were mostly affected in 
survivors without significant disabilities at follow-up or 
without a stroke were nonspecific items such as “energy” 
and “thinking”. This may reflect the patient’s general 
concern and represent a psychological phenomenon, 
because physical function-related items such as “self-
care”, “social roles”, “mobility” and “upper extremity 
function” were barely affected. The item “mood” was not 
affected. Therefore, the deterioration in QOL is unlikely 
to be due to major depression, a common important 
contributing factor of an impaired QOL. 
The most appropriate end-point in follow-up studies 
after sCAD is still under debate: recurrence rate is low; 
lack of complete morphological recovery of the affected 
vessel does not seem to be an appropriate outcome mea-
sure unless it is accompanied by an ischemic stroke, and 
traditional functional outcome measurements such as 
mRS show ceiling effects [19]. Half of our patients had a 
mRS of 0 and 72 % a mRS of 0 or 1. QOL scales on the 
other hand measure not only functional outcomes but 
also assess psychological and cognitive functions like 
memory, emotion, thinking, communication and social 
role. In the present study, QOL was more sensitive than 
traditional outcome measures and was able to assess se-
quelae in patients with local symptoms only and in those 
without functional deficits at follow-up. Previous stud-
ies of QOL in patients after sCAD are scarce: to our 
knowledge, QOL has never been assessed in patients af-
ter carotid artery dissections and in patients with sCAD 
without concomitant ischemic events. To date, there is 
only one retrospective study of 30 patients with a stroke 
due to VAD: Czechowsky et al. found a poorer outcome 
on QOL measures than on standard stroke scales, which 
is in line with our results [20]. 
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Fig. 3  SS-QOL in patients before spontaneous 
cervical artery dissection (sCAD) and in survivors 
with and without stroke. SS-QOL ranges from 1 
to 5 with higher scores indicating better function. 
mRS modified Rankin Scale; Stroke all patients with 
ischemic stroke and or retinal ischemia; No Stroke 
all patients with a transient ischemic attack or local 
symptoms; UE function upper extremity function
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In a multivariate regression analysis, high NIHSS 
score on admission and higher age were independent 
predictors of impaired QOL. In a previous study of 195 
survivors after VAD low baseline NIHSS and younger 
age were independent predictors of a favorable func-
tional outcome (mRS 0–1) [21]. Because of the correla-
tion of mRS and QOL our results are in line with these 
data. 
Our study has several limitations. A total of 25 % of 
survivors were unable to complete the questionnaire 
without help. Patients’ perception of QOL and caregiv-
ers’ perception may vary [22, 23]. However only 8 % 
without a stroke and 8 % without significant disability 
needed help by their proxies. Therefore, it seems unlikely 
that these results might have substantially influenced 
our results. 
Another limitation is the wide range of time to fol-
low-up inquiry. However all patients had at least one 
year of follow-up. Because most of the changes after a 
stroke occur within a few months and changes after 
years are usually small, it is unlikely that this might have 
biased our results. Thomassen et al. showed in an analy-
sis, assessing mRS 3, 6 and 12 months after intravenous 
thrombolysis that major improvement does not occur 
between 3 to 12 months [24]. Outcome in 173 patients 
after intraarterial thrombolysis of our own cohort was 
sustained two years after thrombolysis and major im-
provement between 3 months and 2 years was not ob-
served [25]. Potentially, new and/or other diseases or life 
conditions might have influenced QOL in our patients 
because of the wide range of time to follow-up. However, 
time to follow-up did not differ significantly in patients 
with and without stroke as well as in patients with mRS 
0–1 and 2–5. Further analyses such as stratification ac-
cording to time to follow-up, were not sensible because 
of the rather small sample size of our study. Further-
more, QOL was related to the functional status, which 
should have decreased in the presence of a severe dis-
abling disease. Moreover marital status – an important 
factor that can influence QOL – did not change in our 
patients. 
Survivors had to rate their QOL before dissection: in 
retrospect, the past might have been perceived more 
pleasantly than the present, as unpleasant conditions 
may have been forgotten. Patients with major disabili-
ties might rate their QOL before their sCAD significantly 
higher and therefore may overestimate the impact of the 
sCAD on their QOL, whereas patients with little disabil-
ities might rate their QOL before dissection too low. 
However, even if patients with no significant functional 
disabilities had underestimated their QOL before their 
sCAD in the present analysis, QOL was still significantly 
lower than before the sCAD. Assessing QOL before dis-
section is impossible and population-based values of SS-
QOL to compare our patients’ condition with healthy 
controls are not available. Therefore, mean SS-QOL in all 
patients before their dissection was assumed as best 
available measure for a good QOL. There was no differ-
ence in rating premorbid QOL by proxies and patients 
and 95 % CI in SS-QOL before dissection was very low. 
This study may provide a basis for further QOL re-
search in patients with sCAD. QOL should be assessed in 
all prospective studies, analyzing outcome in patients 
with sCAD and should be compared with healthy con-
trols. Mediator variables such as coping behavior, re-
sponse shift, benefit finding and aspects of individual 
QOL assessment should be focused in further studies.
In conclusion QOL is significantly impaired in long-
term survivors after sCAD, even in patients with local or 
transient symptoms only and in patients without func-
tional disability. QOL is more sensitive than traditional 
outcome scales to assess sequelae after sCAD and de-
serves attention as an outcome measure in these pa-
tients. 
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